Article info
Cancer genetics
Short report
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options
- Correspondence to Dr Camille Tlemsani, Service d’Oncologie Médicale, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, AP-HP, Paris 75014, France; camille.tlemsani{at}aphp.fr
Citation
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options
Publication history
- Received July 8, 2018
- Revised September 26, 2018
- Accepted October 4, 2018
- First published October 23, 2018.
Online issue publication
January 23, 2020
Article Versions
- Previous version (23 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.